Suraksha Diagnostic Limited

BSE: 544293 NSE: SURAKSHA
Suraksha Diagnostic Limited - healthcare in Kolkata, West Bengal, India. FY 2026 financials & compliance.
CIN L85110WB2005PLC102265 Incorporated 15 March 2005 ROC Kolkata HQ Kolkata, West Bengal, India
Active Listed - NSE: SURAKSHA · BSE: 544293 Public Limited Company healthcare
Data last updated
Market Cap
₹1,510 Cr
SURAKSHA · NSE
Share Price
₹289.10
-0.29% today
Revenue
₹310 Cr
FY 2025-26 · +23.1% YoY
EBITDA
₹96.17 Cr
Margin 31.0%
Net Profit
₹32.37 Cr
FY 2025-26 · +1.1% YoY
P/E (TTM)
43.4x
P/B 6.3x
ROE
13.8%
ROCE 16.6%
Debt / Equity
0.48
Interest cover 24.4x

About Suraksha Diagnostic Limited

Data last updated:

Suraksha Diagnostic Limited is a public limited company based in Kolkata, West Bengal, India. It operates in the other hospital and medical care activities segment of the healthcare sector. It was incorporated on 15 March 2005 and has been in existence for over 21 years.

The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN L85110WB2005PLC102265. Its GSTIN is 19AAJCS4356F1Z3 (West Bengal). The company holds 4 GST registrations, of which 2 are active. Its shares are listed on BSE: 544293 and NSE: SURAKSHA.

The company has an authorised share capital of ₹14 Cr and a paid-up capital of ₹10.42 Cr. It is led by directors including Somnath Chatterjee (Managing Director) and Ritu Mittal (Managing Director).

Its last annual general meeting (AGM) was held on 05 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No Dg – 12/1 Action Area 1D Premises No 02 – 0327 New Town Rajarhat, Kolkata, West Bengal, India – 700156.

As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹310.41 Cr, a growth of 23.1% compared to the previous year. For the same year it recorded a net profit of ₹32.37 Cr (net margin 10.4%) and EBITDA of ₹96.17 Cr (EBITDA margin 31%). The net worth stands at ₹244.85 Cr (up 15.9% YoY). Total assets are valued at ₹396.52 Cr (up 32.1% YoY).

The company has about 1,415 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.

The company is associated with 1 brand: Suraksha Diagnostics. As per MCA filings, the company has open charges of ₹76.95 Cr and satisfied charges of ₹274.15 Cr on record. Court records list 4 cases involving the company, including 3 filed by the company and 1 filed against it. The company has 14 deals on record (6 secondary share transfers, 3 funding rounds, 2 market trades), with disclosed funding of ₹26.2 Cr; the latest was in May 2025. Its 10 peer companies in the Healthcare industry (Diagnostics and Pathology Labs) are compared by revenue, 5 larger and 5 smaller; the largest is DDRC Agilus Pathlabs Limited with revenue of ₹322 Cr.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website surakshanet.com.

Company Details of Suraksha Diagnostic Limited
CIN L85110WB2005PLC102265
Registration Number 102265
Incorporation Date 15 March 2005
ROC Kolkata
Listing Status Listed (BSE: 544293, NSE: SURAKSHA)
Company Status Active
Date of Last AGM 05 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant

CIN History of Suraksha Diagnostic Limited

Suraksha Diagnostic has one previous CIN (Corporate Identification Number): U85110WB2005PTC102265. The current CIN is L85110WB2005PLC102265, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
L85110WB2005PLC102265Current
U85110WB2005PTC102265Previous
Key People
Somnath Chatterjee Managing Director Ritu Mittal Managing Director Pradip Kumar Dutta Director
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    surakshanet.com
  • Social Media
  • Apps
  • Registered Address
    Plot No Dg – 12/1 Action Area 1D Premises No 02 – 0327 New Town Rajarhat, Kolkata, West Bengal, India – 700156
  • Industry
    Healthcare, Other Hospital And Medical Care Activities
Comprehensive company report
Suraksha Diagnostic Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Suraksha Diagnostic Limited report

Financials, compliance, directors, charges, ownership and filings for Suraksha Diagnostic Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

Associated Brands with Suraksha Diagnostic Limited

Suraksha Diagnostic operates one associated brand: Suraksha Diagnostics. Each brand links to its own profile.

BrandDescriptionWebsite
Suraksha Diagnostics
Pathology, molecular diagnostics, and imaging services are provided.surakshanet.com

Business Activity of Suraksha Diagnostic Limited

The main business activity of Suraksha Diagnostic is hospital and medical care. In detail, this covers other hospital and medical care activities.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
QHospital and Medical CareQ6Other Hospital and Medical Care ActivitiesLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Suraksha Diagnostic Limited FY 2025-26 filings available

Suraksha Diagnostic Limited reported revenue of ₹310.41 Cr (up 23.1% YoY) for FY 2025-26.

Financial Highlights

FY 2025-26 · Consolidated
Revenue
₹310 Cr
+23.1% YoY
EBITDA
₹96.17 Cr
+17.4% YoY
Profit After Tax
₹32.37 Cr
+1.1% YoY
Net Worth
₹245 Cr
+15.9% YoY
Total Assets
₹397 Cr
+32.1% YoY
Total Debt
₹130 Cr
+46.6% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue310252219190223140158
Revenue growth+23.1%+15.3%+15.0%-14.8%+59.4%-11.1%-
EBITDA96.1781.9370.1144.4348.0822.6234.10
EBITDA margin+31.0%+32.5%+32.1%+23.4%+21.5%+16.2%+21.7%
Profit before tax44.5441.4131.466.7533.196.3921.02
Net profit32.3732.0325.677.6824.768.1415.00
Net profit margin+10.4%+12.7%+11.7%+4.0%+11.1%+5.8%+9.5%
EPS (₹)6.186.1134.249.45344.2093.26220.48
Balance sheet
Total assets397300270253169143131
Net worth245211179156150126120
Total debt13088.8990.4896.8819.0216.4311.59
Cash & bank26.3520.1155.0255.042.824.433.92
Net working capital18.9719.2348.0146.220.443.49(7.26)
Cash flow
Cash from operations81.8363.3660.4844.1042.3423.5131.31
Cash from investing(52.17)(39.58)(35.00)(20.79)(43.79)(27.71)(19.79)
Cash from financing(28.69)(24.05)(25.13)(24.33)1.093.21(10.16)
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue87.6581.4177.6978.7372.5965.0959.5166.75
Revenue growth (YoY)+20.8%+25.1%+30.6%+18.0%+19.5%---
Other income1.090.790.620.850.910.820.601.31
EBITDA30.4524.3723.1624.1223.7519.1818.2523.19
EBITDA margin+34.7%+29.9%+29.8%+30.6%+32.7%+29.5%+30.7%+34.7%
Depreciation11.2811.2610.5610.149.488.738.838.75
Interest3.723.923.162.782.702.061.982.13
Profit before tax16.549.9810.0612.0512.489.218.0413.62
Tax3.683.822.823.223.302.042.063.48
Net profit12.866.167.248.839.187.175.9810.14
EPS (₹)2.501.211.441.731.801.421.181.94
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue301249219190223140158
Revenue growth+20.7%+14.0%+15.0%-14.9%+59.4%-11.1%-
EBITDA95.5483.2671.1945.4848.0922.6634.10
EBITDA margin+31.8%+33.4%+32.6%+23.9%+21.6%+16.2%+21.7%
Profit before tax47.2243.8632.707.8733.206.4321.02
Net profit34.2833.6326.468.5323.768.1815.00
Net profit margin+11.4%+13.5%+12.1%+4.5%+10.7%+5.8%+9.5%
EPS (₹)6.546.4235.3410.42344.2293.83220.48
Balance sheet
Total assets400304272254169143131
Net worth250214181157150126120
Total debt12888.8990.4896.8819.0216.4311.59
Cash & bank25.2415.5352.8154.622.834.353.82
Net working capital21.8920.8546.5046.120.523.47(7.31)
Cash flow
Cash from operations80.2362.8061.2344.9342.3323.5431.31
Cash from investing(51.25)(39.28)(35.04)(22.04)(43.69)(27.71)(19.90)
Cash from financing(28.15)(24.15)(25.83)(24.32)1.093.21(10.16)
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue84.0978.5675.5876.2670.2864.1558.5765.95
Revenue growth (YoY)+19.7%+22.5%+29.0%+15.6%+16.3%---
Other income1.561.300.990.971.100.940.971.26
Total expenses55.1754.7552.3952.2946.4444.3240.4842.37
EBITDA28.9223.8123.1923.9723.8419.8318.0923.58
EBITDA margin+34.4%+30.3%+30.7%+31.4%+33.9%+30.9%+30.9%+35.8%
Depreciation10.6010.6910.119.659.158.668.628.58
Interest3.673.873.102.722.662.062.032.07
Profit before tax16.2110.5510.9712.5713.1310.058.4114.19
Tax3.633.842.823.203.282.032.063.43

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 22 Oct 2026
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue87.6581.4177.6978.7372.5965.0959.5166.75
Revenue growth (YoY)+20.8%+25.1%+30.6%+18.0%+19.5%---
Other income1.090.790.620.850.910.820.601.31
EBITDA30.4524.3723.1624.1223.7519.1818.2523.19
EBITDA margin+34.7%+29.9%+29.8%+30.6%+32.7%+29.5%+30.7%+34.7%
Depreciation11.2811.2610.5610.149.488.738.838.75
Interest3.723.923.162.782.702.061.982.13
Profit before tax16.549.9810.0612.0512.489.218.0413.62
Tax3.683.822.823.223.302.042.063.48
Net profit12.866.167.248.839.187.175.9810.14
EPS (₹)2.501.211.441.731.801.421.181.94
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue310252219190223140158
Revenue growth+23.1%+15.3%+15.0%-14.8%+59.4%-11.1%-
Other income3.163.853.553.552.301.381.54
Total expenses214170149146175117123
Employee cost53.2642.8940.0739.8231.2623.0831.92
EBITDA96.1781.9370.1144.4348.0822.6234.10
EBITDA margin+31.0%+32.5%+32.1%+23.4%+21.5%+16.2%+21.7%
Depreciation41.4535.3032.6031.6715.0915.7112.59
Interest13.349.079.609.562.101.902.03
Profit before tax44.5441.4131.466.7533.196.3921.02
Tax13.1610.428.330.689.44(0.06)5.80
Net profit32.3732.0325.677.6824.768.1415.00
Net profit margin+10.4%+12.7%+11.7%+4.0%+11.1%+5.8%+9.5%
EPS (₹)6.186.1134.249.45344.2093.26220.48
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital10.4210.428.538.538.538.538.53
Reserves & surplus234201171147141118111
Shareholders' funds (net worth)245211179156150126120
Minority interest(1.37)(1.01)(0.26)(0.47)0.000.000.00
Secured loans1.295.428.6414.0117.6214.837.57
Unsecured loans12983.4781.8482.871.401.604.02
Total debt13088.8990.4896.8819.0216.4311.59
Total liabilities397300270253169143131
Assets
Gross block453320274226211198194
Net block315223212195119119128
Capital work in progress36.9410.591.312.391.240.160.38
Investments0.001.000.000.000.005.415.38
Inventories8.148.056.686.166.234.455.45
Sundry debtors22.7613.818.874.687.576.006.00
Cash & bank balances26.3520.1155.0255.042.824.433.92
Loans & advances5.325.191.872.175.197.067.58
Total current assets62.5747.1672.4468.0521.8121.9422.95
Total current liabilities43.6027.9324.4321.8321.3718.4530.21
Net working capital18.9719.2348.0146.220.443.49(7.26)
Total assets397300270253169143131
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash2.252.522.163.192.933.922.56
Net cash from operating activities81.8363.3660.4844.1042.3423.5131.31
Net cash from investing activities(52.17)(39.58)(35.00)(20.79)(43.79)(27.71)(19.79)
Net cash from financing activities(28.69)(24.05)(25.13)(24.33)1.093.21(10.16)
Net change in cash0.97(0.27)0.36(1.03)(0.36)(0.99)1.36
Closing cash26.3520.1155.0255.042.824.433.92
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+23.1%+15.3%+15.0%-14.8%+59.4%-11.1%-
EBITDA growth+17.4%+16.9%+57.8%-7.6%+112.6%-33.7%-
PBT growth+7.6%+31.6%+366.1%-79.7%+419.4%-69.6%+9997.0%
Net income growth+1.1%+24.8%+234.2%-69.0%+204.2%-45.7%-
Revenue CAGR (3Y)+17.8%+4.1%+16.0%+6.5%---
EBITDA CAGR (3Y)+29.4%+19.4%+45.8%+9.2%---
Profitability & leverage
Net income margin+10.1%+12.3%+10.6%+3.2%+10.6%+4.6%+9.7%
Return on capital employed+16.6%+17.7%+15.7%+8.9%+22.6%+7.6%+17.5%
Return on net worth+13.8%+15.9%+13.9%+4.8%+17.4%+6.7%+12.9%
Debt / equity0.480.460.560.380.130.110.10
Long-term debt / equity0.410.380.460.300.080.070.06
Interest cover24.3819.4525.5974.926.3727.509.44
Efficiency & per share
Fixed asset turnover0.800.850.870.871.090.710.81
Inventory turnover38.3534.2334.0730.6941.8028.2828.90
Debtors turnover16.9822.2332.2831.0432.8923.3426.25
EPS (₹)6.186.1134.249.45344.2093.26220.48
Dividend per share (₹)0.050.000.000.000.000.000.00
Book value per share (₹)47.0140.56257.65223.622,149.921,805.721,712.46
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue84.0978.5675.5876.2670.2864.1558.5765.95
Revenue growth (YoY)+19.7%+22.5%+29.0%+15.6%+16.3%---
Other income1.561.300.990.971.100.940.971.26
Total expenses55.1754.7552.3952.2946.4444.3240.4842.37
EBITDA28.9223.8123.1923.9723.8419.8318.0923.58
EBITDA margin+34.4%+30.3%+30.7%+31.4%+33.9%+30.9%+30.9%+35.8%
Depreciation10.6010.6910.119.659.158.668.628.58
Interest3.673.873.102.722.662.062.032.07
Profit before tax16.2110.5510.9712.5713.1310.058.4114.19
Tax3.633.842.823.203.282.032.063.43
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue301249219190223140158
Revenue growth+20.7%+14.0%+15.0%-14.9%+59.4%-11.1%-
Other income4.354.383.653.582.301.381.54
Total expenses205166147145175117123
Employee cost51.6741.9139.6439.4634.1423.0531.92
EBITDA95.5483.2671.1945.4848.0922.6634.10
EBITDA margin+31.8%+33.4%+32.6%+23.9%+21.6%+16.2%+21.7%
Depreciation39.6034.7332.5731.6315.0915.7112.59
Interest13.079.059.579.562.101.902.03
Profit before tax47.2243.8632.707.8733.206.4321.02
Tax13.1510.428.320.689.44(0.06)5.80
Net profit34.2833.6326.468.5323.768.1815.00
Net profit margin+11.4%+13.5%+12.1%+4.5%+10.7%+5.8%+9.5%
EPS (₹)6.546.4235.3410.42344.2293.83220.48
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital10.4210.428.538.538.538.538.53
Reserves & surplus239204172148141118111
Shareholders' funds (net worth)250214181157150126120
Secured loans1.225.428.5214.0119.0214.837.57
Unsecured loans12783.4781.9682.870.001.604.02
Total debt12888.8990.4896.8819.0216.4311.59
Total liabilities400304272254169143131
Assets
Gross block419312274226211198194
Net block284215211195119119128
Capital work in progress36.815.811.022.391.090.160.38
Investments6.312.711.160.500.165.525.48
Inventories8.128.026.656.046.234.455.45
Sundry debtors24.8615.069.154.697.576.006.00
Cash & bank balances25.2415.5352.8154.622.834.353.82
Loans & advances5.255.672.142.305.247.117.63
Total current assets63.4744.2870.7567.6521.8721.9122.90
Total current liabilities41.5823.4324.2521.5321.3518.4430.21
Net working capital21.8920.8546.5046.120.523.47(7.31)
Total assets400304272254169143131
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash1.482.111.753.192.863.822.56
Net cash from operating activities80.2362.8061.2344.9342.3323.5431.31
Net cash from investing activities(51.25)(39.28)(35.04)(22.04)(43.69)(27.71)(19.90)
Net cash from financing activities(28.15)(24.15)(25.83)(24.32)1.093.21(10.16)
Net change in cash0.83(0.63)0.36(1.44)(0.28)(0.96)1.26
Closing cash25.2415.5352.8154.622.834.353.82
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+20.7%+14.0%+15.0%-14.9%+59.4%-11.1%-
EBITDA growth+14.8%+17.0%+56.5%-5.4%+112.2%-33.6%-
PBT growth+7.7%+34.1%+315.5%-76.3%+416.3%-69.4%-4.0%
Net income growth+1.9%+27.1%+210.2%-64.1%+190.5%-45.5%-
Revenue CAGR (3Y)+16.5%+3.7%+16.0%+6.5%+13.9%+2.0%-
EBITDA CAGR (3Y)+28.1%+20.1%+46.5%+10.1%+10.9%-4.0%-
Profitability & leverage
Net income margin+11.3%+13.4%+11.2%+3.8%+10.7%+4.6%+9.7%
Return on capital employed+17.1%+18.4%+16.1%+9.4%+22.6%+7.6%+17.2%
Return on net worth+14.7%+17.0%+14.6%+5.6%+17.4%+6.7%+13.8%
Debt / equity0.470.450.560.380.130.110.14
Long-term debt / equity0.400.380.460.300.080.070.07
Interest cover23.3618.6524.7869.036.3627.349.44
Efficiency & per share
Fixed asset turnover0.820.850.870.871.090.710.84
Inventory turnover37.2633.9634.4430.9741.8028.2827.80
Debtors turnover15.0620.5831.5830.9932.8923.3425.30
EPS (₹)6.546.4235.3410.42344.2293.83220.48
Dividend per share (₹)0.050.000.000.000.000.000.00
Book value per share (₹)47.9641.15259.76224.632,150.511,806.301,712.46
Want more history and ratios?
You're viewing the latest exchange-filed financials for Suraksha Diagnostic Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Board of Directors of Suraksha Diagnostic Limited

Suraksha Diagnostic has 7 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Somnath Chatterjee
Also directs: Suraksha Speciality LLP, Suraksha Salvia LLP, Sahayta Clinic LLP and 5 more
Managing Director15 Mar 200521 Years 7 MonthsCurrent
Ritu Mittal
Also directs: Suraksha Speciality LLP, Fetomat Wellness Private Limited, Somatist Therapeutics Private Limited and 5 more
Managing Director08 Nov 200619 Years 11 MonthsCurrent
Pradip Kumar DuttaDirector16 Jul 20242 Years 3 MonthsCurrent
Satish Kumar Verma
Also directs: SRD Agencies LLP, Reliance Electronic Industries (India) LLP, Asv Electronics LLP and 5 more
Director16 Jul 20242 Years 3 MonthsCurrent
Ishani Ray
Also directs: Gloster Limited, Emami Realty Limited, Abc India Limited and 4 more
Director16 Jul 20242 Years 3 MonthsCurrent
Siddhartha Roy
Also directs: Amgoorie India Ltd
Director03 Oct 20242 Years 0 MonthsCurrent
Showing 6 of 7 current directors. View all directors

Peer Comparison of Suraksha Diagnostic Limited

Suraksha Diagnostic Limited is compared with the companies closest to it by revenue in the Healthcare industry (Diagnostics and Pathology Labs). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
DDRC Agilus Pathlabs Limited₹322 Cr (FY 2025)••••••••15.0%••••Mumbai, Maharashtra, India
Ayushman Medical Diagnostics Pvt Ltd₹318.4 Cr (FY 2025)••••••••11.0%••••Bhopal, Madhya Pradesh, India
Suraksha Diagnostic Limited this company₹310.41 Cr (FY 2026)••••••••23.1%••••Kolkata, West Bengal, India
Agilus Pathlabs Private Limited₹285.22 Cr (FY 2025)••••••••4.0%••••Delhi, India
Premier Medical Corporation Private Limited₹274.53 Cr (FY 2025)••••••••-47.0%••••Sarigam, Gujarat, India
Aarthi Scans Private Limited₹268.15 Cr (FY 2024)••••••••18.0%••••Chennai, Tamil Nadu, India
CSC Healthcare & Wellness Services Limited₹255.48 Cr (FY 2025)••••••••14.0%••••Delhi, India
Pathkind Diagnostics Private Limited₹246.27 Cr (FY 2025)••••••••4.0%••••New Delhi, Delhi, India
Healthmap Diagnostics Private Limited₹216.94 Cr (FY 2025)••••••••17.0%••••Bangalore, Karnataka, India
Spandan Diagnostic Centre Private Limited₹213.73 Cr (FY 2025)••••••••7.0%••••Paschim Midnapore, West Bengal, India
Anderson Diagnostic Services Private Limited₹204.12 Cr (FY 2025)••••••••30.0%••••Chennai, Tamil Nadu, India

Peers are the five companies nearest above and the five nearest below Suraksha Diagnostic by revenue in the Healthcare industry (Diagnostics and Pathology Labs), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Suraksha Diagnostic Limited

Suraksha Diagnostic Limited is audited by Deloitte Haskins & Sells LLP for the financial year 2023.

NameStatusAppointment DateCessation Date
Deloitte Haskins & Sells LLPLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Shareholding Pattern of Suraksha Diagnostic Limited

Shareholding for the quarter ended Sep 2026: promoters hold 49.10%, foreign institutional investors hold 13.50%, domestic institutional investors hold 23.20% and retail and other public shareholders hold 14.20%.

Promoters: 49.10%DII (Domestic Institutional): 23.20%FII (Foreign Institutional): 13.50%Retail & Others: 14.20%
Sep 2026
QUARTER
49.10% Promoters
23.20% DII (Domestic Institutional)
13.50% FII (Foreign Institutional)
14.20% Retail & Others
Promoter holding - history
Now 49.10% · Sep 2026High 49.10% · Jun 2026Low 49.00% · Dec 2025
48%48.8%49.5%50.3%51%Dec 2025Mar 2026Jun 2026Sep 2026Dec 2025: 49.00%Mar 2026: 49.00%Jun 2026: 49.10%Sep 2026: 49.10%49.10%49.00%49.10%
Shareholding trend - last 6 quarters
Sep 2026Jun 2026Mar 2026Dec 2025
Promoters49.10%49.10%49.00%49.00%
Public50.90%50.90%51.00%51.00%

Charges & Borrowings of Suraksha Diagnostic Limited

Open charges
₹76.95 Cr
Satisfied charges
₹274.15 Cr
Breakdown by lending institutions
Hdfc Bank Limited₹56.72 Cr
Axis Bank Limited₹19.63 Cr
Others₹0.60 Cr
Latest charge details
DateLenderAmountStatus
20 Jul 2026Hdfc Bank Limited₹46 CrOpen
30 Jan 2026Axis Bank Limited₹9.82 CrOpen
30 Jan 2026Axis Bank Limited₹1.41 CrOpen
15 Dec 2025Axis Bank Limited₹8.4 CrOpen
20 Feb 2025Others₹60 LakhOpen

Total charge records: 51 View all charges

Deals & Funding of Suraksha Diagnostic Limited

Suraksha Diagnostic Limited has 14 deals on record (6 secondary share transfers, 3 funding rounds, 2 market trades), with disclosed funding of ₹26.2 Cr; the latest was in May 2025.

Total deals
14
Secondary share transfers
6
Funding rounds
3
Market trades
2
Acquisitions
2
Disclosed funding
₹26.2 Cr

Deals on record (5 of 14)

WhenDealAmountParties
Dec 2024Market trade₹16.38 CrBuyer: Aakraya Research LLP
Seller: Aakraya Research LLP
Oct 2021Secondary share transferUndisclosedBuyer: 2 individuals
Seller: Panorama Electronics Pvt Ltd , 2 individuals
Mar 2021Secondary share transferUndisclosedBuyer: an individual
Seller: Suraksha Diagnostic & Eye Centre Private Limited
Jan 2013Secondary share transferUndisclosedBuyer: 2 individuals
Seller: Oscar International Limited , Oscar Marketing Company Private Limited
Aug 2010Funding round₹3.51 CrInvestors: Tinni Investments Ltd , 3 individuals
Premium access

Full deal history

All 14 deals with amounts, valuations, instruments and every party are in the company report.

  • Every funding round and share transfer
  • Amounts and valuations
  • Investors, buyers and sellers
  • Instruments and deal dates

Verified entity values are shown only after access is granted.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

Employees and EPFO Compliance at Suraksha Diagnostic Limited

Suraksha Diagnostic Limited has a workforce of 1,415 employees as of Mar 24, 2024.

Employee count
1,415
Active EPFO establishments
1
Employee growth
-24.21%
Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Group Structure of Suraksha Diagnostic Limited

Suraksha Diagnostic has 1 subsidiary company. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.

1
Subsidiary companies
Key Subsidiaries
Company NameCINShares Held
Suraksha Radiology Private LimitedU86905WB2023PTC265197-

Showing major subsidiaries. Total: 1.

Recent Activity on Suraksha Diagnostic Limited

Suraksha Diagnostic Limited has 22 board changes on record since 2005: 15 appointments and 7 cessations. The latest: Arun Sadhanandham ceased to be Nominee Director on 07 Jun 2025.

Charges
A charge with Hdfc Bank Limited of Rs. 46.00 Cr registered on 20 Jul 2026 with Charge ID 101370269 was modified on 29 Jul 2026.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 46.00 Cr with Charge ID 101370269 was registered on 20 Jul 2026.
Charges
A charge with Axis Bank Limited amounted to Rs. 9.82 Cr with Charge ID 101229621 was registered on 30 Jan 2026.
Charges
A charge with Axis Bank Limited amounted to Rs. 1.41 Cr with Charge ID 101229624 was registered on 30 Jan 2026.
Charges
A charge with Axis Bank Limited amounted to Rs. 8.40 Cr with Charge ID 101208743 was registered on 15 Dec 2025.
AGM
Suraksha Diagnostic Limited last Annual general meeting of members was held on 05 Sep 2025 as per latest MCA records.
Charges
A charge registered on 30 Oct 2019 via Charge ID 100308102 with Hdfc Bank Limited was fully satisfied on 07 Aug 2025.
Charges
A charge registered on 18 Oct 2021 via Charge ID 100490832 with Others was fully satisfied on 15 Jul 2025.
Ceased
Arun Sadhanandham ceased to be Nominee Director.
Filing
Suraksha Diagnostic Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kolkata I.
Appointed
Kanakayya Sathyamurthy Ravindra was appointed as CFO.
Charges
A charge with Others amounted to Rs. 0.60 Cr with Charge ID 101066118 was registered on 20 Feb 2025.

109 earlier events are listed in the company report.

Credit Ratings, Litigation & Regulatory Alerts for Suraksha Diagnostic Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Suraksha Diagnostic Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Suraksha Diagnostic Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Suraksha Diagnostic Limited

Suraksha Diagnostic has 4 GST registrations: 2 active and 2 cancelled or inactive.

Total GSTINs
4
Active
2
Cancelled / inactive
2
GSTINStateStatusRegistered on
19AAJCS4356F1Z3West BengalActive01 Jul 2017
10AAJCS4356F2ZKBiharActive18 Aug 2017
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Suraksha Diagnostic Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Related news about Suraksha Diagnostic Limited

Frequently Asked Questions about Suraksha Diagnostic Limited

Suraksha Diagnostic is an active public limited company based in Kolkata, West Bengal, India. The company works in other hospital and medical care activities, within the healthcare industry. It was incorporated on 15 March 2005 (21+ years old) and is registered under CIN L85110WB2005PLC102265. Listed on BSE: 544293 and NSE: SURAKSHA.

Suraksha Diagnostic reported revenue of ₹310.41 Cr for FY 2025-26 (up 23.1% YoY) based on consolidated financials.

Suraksha Diagnostic has 7 current directors:

The GSTIN of Suraksha Diagnostic is 19AAJCS4356F1Z3, registered in West Bengal. The company has 4 GST registrations in all, of which 2 are active and 2 are cancelled or inactive. Other active GSTINs include 10AAJCS4356F2ZK (Bihar).

The CIN (Corporate Identification Number) of Suraksha Diagnostic is L85110WB2005PLC102265. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Yes. Suraksha Diagnostic is listed on both BSE (code: 544293) and NSE (symbol: SURAKSHA).

Suraksha Diagnostic has 4 court cases on record: 3 filed by the company and 1 filed against it.

Suraksha Diagnostic was incorporated on 15 March 2005, making it 21+ years old. It is registered with the Registrar of Companies, Kolkata.

Suraksha Diagnostic has 14 deals on record (6 secondary share transfers, 3 funding rounds, 2 market trades), with disclosed funding of ₹26.2 Cr; the latest was in May 2025.

The peers of Suraksha Diagnostic by revenue are DDRC Agilus Pathlabs Limited, Ayushman Medical Diagnostics Pvt Ltd, Agilus Pathlabs Private Limited, Premier Medical Corporation Private Limited, Aarthi Scans Private Limited and 5 more, all in the Healthcare industry (Diagnostics and Pathology Labs).

Arun Sadhanandham ceased to be Nominee Director on 07 Jun 2025. Kanakayya Sathyamurthy Ravindra was appointed as CFO on 06 Mar 2025. Dharam Chand Dharewa was appointed as Director on 03 Oct 2024. Suraksha Diagnostic has 22 board changes on record in total.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available